cladribine and its Impurities

Cladribine is used for as a first and second-line treatment for symptomatic hairy cell leukemia and for B-cell chronic lymphocytic leukemia and is administered by intravenous or subcutaneous infusion. It is sold under the brand name Leustatin and Mavenclad.. Reference standards of Cladribine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 20 results for cladribine Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 30 45000

Cladribine

Cladribine

  • Catalogue No.:PA 30 45000

  • CAS :

    4291-63-8

  • Molecular Formula : C10H12ClN5O3

  • Molecular Weight : 285.69

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 45030

Cladribine - Impurity C

2-Chloroadenine

  • Catalogue No.:PA 30 45030

  • CAS :

    1839-18-5

  • Molecular Formula : C5H4ClN5

  • Molecular Weight : 169.57

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 45050

Cladribine - Impurity E

2-Deoxy-D-erythro-pentose

  • Catalogue No.:PA 30 45050

  • CAS :

    1831121-84-6

  • Molecular Formula : C5H10O4

  • Molecular Weight : 134.13

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 45060

Cladribine - Impurity F

4-Methylbenzamide

  • Catalogue No.:PA 30 45060

  • CAS :

    619-55-6

  • Molecular Formula : C8H9NO

  • Molecular Weight : 135.16

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 45070

Cladribine - Impurity G

Methyl 4-Methylbenzoate

Drug Reference Standards & Impurity Synthesis in India

  • Catalogue No.:PA 30 45070

  • CAS :

    99-75-2

  • Molecular Formula : C9H10O2

  • Molecular Weight : 150.17

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 45510

Propyl 4-methylbenzoate

Propyl 4-methylbenzoate

  • Catalogue No.:PA 30 45510

  • CAS :

    9015-73-0

  • Molecular Formula : C11H14O2

  • Molecular Weight : 178.23

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA USP1134211

Cladribine Related Compound A (2-methoxy-2'-deoxyadenosine) (1134211)

Cladribine Related Compound A (2-methoxy-2'-deoxyadenosine) (1134211)

  • Catalogue No.:PA USP1134211

  • CAS :

    24757-70-8

  • Molecular Formula : NA

  • Molecular Weight : NA

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA USP1134200

Cladribine (1134200)

Cladribine (1134200)

  • Catalogue No.:PA USP1134200

  • CAS :

    4291-63-8

  • Molecular Formula : NA

  • Molecular Weight : NA

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA EPY0000639

Cladribine (Y0000639)

Cladribine (Y0000639)

  • Catalogue No.:PA EPY0000639

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA EPY0000610

Cladribine impurity C (Y0000610)

Cladribine impurity C (Y0000610)

  • Catalogue No.:PA EPY0000610

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA EPY0000609

Cladribine for peak identification (Y0000609)

Cladribine for peak identification (Y0000609)

  • Catalogue No.:PA EPY0000609

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 45520

3’-Amino-2’,3’-dideoxyguanosine

3’-Amino-2’,3’-dideoxyguanosine

  • Catalogue No.:PA 30 45520

  • CAS :

    66323-49-7

  • Molecular Formula : C10H14N6O3

  • Molecular Weight : 266.26

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 0450010

Cladribine - Impurity A

9-(2-Deoxy-β-D-erythro-pentofuranosyl)-9H-purin-2,6-diamine

  • Catalogue No.:PA 30 0450010

  • CAS :

    4546-70-7

  • Molecular Formula : C10H14N6O3

  • Molecular Weight : 266.26

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 0450020

Cladribine - Impurity B

9-(2-Deoxy-β-D-erythro-pentofuranosyl)-2-methoxy-9H-purin-6-amine

  • Catalogue No.:PA 30 0450020

  • CAS :

    24757-70-8

  • Molecular Formula : C11H15N5O4

  • Molecular Weight : 281.27

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 0450040

Cladribine - Impurity D

2-chloro-9-(2′-deoxy-α-D-ribofuranosyl)adenine

  • Catalogue No.:PA 30 0450040

  • CAS :

    5542-92-7

  • Molecular Formula : C10H12ClN5O3

  • Molecular Weight : 285.69

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 0451000

(2R,3S,5R)-5-(6-Amino-2-chloro-7H-purin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

(2R,3S,5R)-5-(6-Amino-2-chloro-7H-purin-7-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol

  • Catalogue No.:PA 30 0451000

  • CAS :

    172792-37-9

  • Molecular Formula : C10H12ClN5O3

  • Molecular Weight : 285.69

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 0451001

Cladribine Mono Benzoate Impurity

Cladribine Mono Benzoate Impurity

  • Catalogue No.:PA 30 0451001

  • CAS :

    152463-98-4

  • Molecular Formula : C18H18ClN5O4

  • Molecular Weight : 403.82

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 30 0451002

2'-Deoxy-α-Adenosine

2'-Deoxy-α-Adenosine

  • Catalogue No.:PA 30 0451002

  • CAS :

    3413-66-9

  • Molecular Formula : C10H13N5O3

  • Molecular Weight : 251.25

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA STI 089613

Cladribine-13C-15N2

Cladribine-13C-15N2

  • Catalogue No.:PA STI 089613

  • CAS :

    NA

  • Molecular Formula : C913CH12ClN315N2O3

  • Molecular Weight : 288.67

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA STI 089631

Cladribine-D4

Cladribine-D4

  • Catalogue No.:PA STI 089631

  • CAS :

    NA

  • Molecular Formula : C10H8D4ClN5O3

  • Molecular Weight : 289.71

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
pharmaffiliates